Skip to main content

Considerations for Coagulation in the Multi‐trauma Patient

  • Chapter
  • First Online:
Anticoagulation and Hemostasis in Neurosurgery

Abstract

Anticoagulation in the multi-trauma patient with traumatic brain injury or spinal cord injury is a complicated issue. Knowledge of the mechanism of action of anticoagulants and reversal agents is key to saving lives. Patients on anticoagulation with brain or spinal cord injury must have their anticoagulation reversed on arrival to prevent further neurological deficits. The timing of prophylactic anticoagulation in the multi-trauma patient is important in preventing venous thromboembolism or worsening intracerebral hemorrhage. Thus, knowledge of the literature regarding anticoagulation in the trauma patient is key to saving lives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Faul MXL, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002–2006. Atlanta, GA: Centers for Disease Control and Prevention; 2010.

    Google Scholar 

  2. National Spinal Cord Injury Statistical Center (2014) Birmingham, Alabama. https://www.nscisc.uab.edu. Accessed 1 Mar 2015.

  3. Denson K, Morgan D, Cunningham R, et al. Incidence of venous thromboembolism in patients with traumatic brain injury. Am J Surg. 2007;193(3):380–3. discussion 383–4.

    Article  PubMed  Google Scholar 

  4. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24):1601–6.

    Article  CAS  PubMed  Google Scholar 

  5. McCoy CC, Lawson JH, Shapiro ML. Management of anticoagulation agents in trauma patients. Clin Lab Med. 2014;34:563–74.

    Article  PubMed  Google Scholar 

  6. Taylor G, Osinski D, Thevenin A, et al. Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery? J Trauma Acute Care Surg. 2013;74(5):1367–9.

    Article  CAS  PubMed  Google Scholar 

  7. Nishijima DK, Zehtabchi S, Berrong J, et al. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J Trauma Acute Care Surg. 2012;72(6):1658–63.

    Article  PubMed  Google Scholar 

  8. Bonville DJ, Ata A, Jahraus CB, et al. Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients. Surgery. 2011;150(4):861–8.

    Article  PubMed  Google Scholar 

  9. Calland JF, Ingraham AM, Martin N, et al. Evaluation and management of geriatric trauma: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012;73(5 Suppl 4):S345–50.

    Article  PubMed  Google Scholar 

  10. Ivascu FA, Howells GA, Junn FS, et al. Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma. 2005;59(5):1131–7 (discussion: 1137–9).

    Article  CAS  PubMed  Google Scholar 

  11. Van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate—a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103(6):1116–27.

    Article  PubMed  Google Scholar 

  12. Boehringer Ingelheim Pharmaceuticals (2013) Pradaxa prescribing information. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=rent&folderPath=/Prescribing%20Information/Pls/Pradaxa/Pradaxa.pdf. Accessed 28 Feb 2015.

  13. Faust AC, Peterson EJ. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report. J Emerg Med. 2014;46(4):525–9.

    Article  PubMed  Google Scholar 

  14. Dumkow LE, Voss JR, Peters M, et al. Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma. Am J Health Syst Pharm. 2012;69(19):1646–50.

    Article  CAS  PubMed  Google Scholar 

  15. Schiele F, van Ryn J, Canada K, et al. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121(18):3554–62.

    Article  CAS  PubMed  Google Scholar 

  16. Perzborn E, Gruber A, Tinel H, et al. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates. Thromb Haemost. 2013;110(1):162–72.

    Article  CAS  PubMed  Google Scholar 

  17. CSL Behring GmbH. Kcentra prescribing information. 2013. Available at: http://www.kcentra.com/prescribing-information.aspx. Accessed 28 Feb 2015.

  18. Furlan JC, Fehlings MG. Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: an evidence-based analysis. Spine. 2007;32(17):1908–16.

    Article  PubMed  Google Scholar 

  19. Reiff DA, Harichan RN, Bullington NM, Griffin RL, McGwin G, Rue LW, et al. Traumatic brain injury associated with the development of deep vein thrombosis independent of pharmacologic prophylaxis. J Trauma. 2009;66(5):1436–40.

    Article  CAS  PubMed  Google Scholar 

  20. Chung SB, Lee SH, Kim ES, et al. Incidence of deep vein thrombosis after spinal cord injury: a prospective study in 37 consecutive patients with traumatic or nontraumatic spinal cord injury treated by mechanical prophylaxis. J Trauma. 2011;71:867–71.

    Article  PubMed  Google Scholar 

  21. Barrera M, Perel P, Ker K, et al (2013) Thromboprophylaxis for trauma patients. Cochrane Database Syst Rev. http://researchonline.lshtm.ac.uk/856572/. Accessed 28 Feb 2015.

  22. Brain Trauma Foundation (2007) J Neurotrauma 24(1). http://online.liebertpub.com/doi/abs/10.1089/neu.2007.9999. Accessed 27 Feb 2015.

  23. Hadley MN, Walters BC, Grabb PA, Oyesiku NM, Przybylski GJ, Resnick DK, Ryken TC. Deep venous thrombosis and thromboembolism in patients with cervical spinal cord injuries. Neurosurgery. 2002;50:S73–80.

    Article  Google Scholar 

  24. Maxwell RA, Chavarria-Aguilar M, Cockerham WT, et al. Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma. 2002;52:902–6.

    Article  PubMed  Google Scholar 

  25. Cothren CC, Smith WR, Moore EE, et al. Utility of once daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multi-system trauma patients. World J Surg. 2007;31:98–104.

    Article  PubMed  Google Scholar 

  26. Kim J, Gearhart MM, Zurick A, et al. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002;53:38–43.

    Article  PubMed  Google Scholar 

  27. Norwood SH, McAuley CE, Berne JD, Vl V, Kerns DB, Grahm TW, et al. Prospective evaluation of the safety of Enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137:696–702.

    Article  CAS  PubMed  Google Scholar 

  28. Minshall CT, Eriksson EA, et al. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury score >2. J Trauma. 2011;71(2):396–400.

    Article  CAS  PubMed  Google Scholar 

  29. Worley S, Short C, Pike J, Anderson D, Douglas JA, Thompson K. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort. J Spinal Cord Med. 2008;31(4):379–87.

    PubMed  PubMed Central  Google Scholar 

  30. Slavik CRS, Gorman E, et al. Dalteparin versus Enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: “DETECT” trial. J Trauma. 2007;62:1075–81 (discussion 1081).

    Article  PubMed  Google Scholar 

  31. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury, part v: deep vein thrombosis prophylaxis. J Neurotrauma. 2007;24 Suppl 1:S32–6.

    PubMed  Google Scholar 

  32. Scudday T, Brasel K, Webb T, et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am Coll Surg. 2011;213(1):148–53. discussion 153–4.

    Article  PubMed  Google Scholar 

  33. Dudley RR, Aziz I, Bonnici A. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular weight heparin: risks and benefits. J Neurotrauma. 2010;27(12):2165–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Craig Rabb M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rabb, C., Williams, A. (2016). Considerations for Coagulation in the Multi‐trauma Patient. In: Loftus, C. (eds) Anticoagulation and Hemostasis in Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-27327-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27327-3_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27325-9

  • Online ISBN: 978-3-319-27327-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics